Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date Read more
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment Read more
ADVANZ PHARMA and Dimerix enter into an Exclusive License Agreement to commercialise DMX-200 in Europe, Canada, Australia, and New Zealand Read more
Unlocking Tomorrow’s Solutions in Chromatography: Purify’23 Conclave – Where Science Meets Innovation Read more
Regeneron and Intellia Announce Expanded Research Collaboration to Develop CRISPR-Based Therapies for the Treatment of Neurological and Muscular Diseases Read more
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies Read more
Karuna Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KarXT for the Treatment of Schizophrenia Read more
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery Read more